Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Two-week Study Assessing the Onset of Effect Questionnaire Administered Pre-dose Versus Post-dose in Adult Subjects

ClinicalTrials.gov ID: NCT00449501

Public ClinicalTrials.gov record NCT00449501. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 30, 2026, 12:37 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Two-week, Randomised, Double-blind Study Assessing the Onset of Effect Questionnaire Administered Pre-dose Versus Post-dose in Adult Subjects (≥ 18 Years) With Mild to Moderate Asthma, Receiving SYMBICORT® pMDI 80/4.5 μg x 2 Actuations Twice Daily or Budesonide HFA pMDI 80 μg x 2 Act. Twice Daily

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to demonstrate whether subjects respond similarly to the Onset of Effect Questionnaire (OEQ) administered pre-dose versus post-dose, while receiving SYMBICORT® pMDI 80/4.5 μg x 2 actuations twice daily or budesonide HFA pMDI 80 μg x 2 actuations twice daily.

Study identification

NCT ID
NCT00449501
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
134 participants

Conditions and interventions

Conditions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2007 (Type not available)
Primary completion
Not listed
Completion
Nov 2007 (Actual)
Last update posted
Jan 24, 2011

2007

United States locations

U.S. sites
46
U.S. states
28
U.S. cities
46
Facility City State ZIP Site status
Research Site Muscle Shoals Alabama — —
Research Site Little Rock Arkansas — —
Research Site Anaheim California — —
Research Site Los Angeles California — —
Research Site Palmdale California — —
Research Site Rolling Hills Estates California — —
Research Site Denver Colorado — —
Research Site Wheat Ridge Colorado — —
Research Site Stamford Connecticut — —
Research Site Wilmington Delaware — —
Research Site Miami Florida — —
Research Site Avon Indiana — —
Research Site Iowa City Iowa — —
Research Site Shawnee Mission Kansas — —
Research Site Mandeville Louisiana — —
Research Site Wheaton Maryland — —
Research Site Bay City Michigan — —
Research Site Chesterfield Missouri — —
Research Site Kansas City Missouri — —
Research Site McCook Nebraska — —
Research Site Scottsbluff Nebraska — —
Research Site Brick New Jersey — —
Research Site Princeton New Jersey — —
Research Site North Syracuse New York — —
Research Site Bismarck North Dakota — —
Research Site Fargo North Dakota — —
Research Site Akron Ohio — —
Research Site Oklahoma City Oklahoma — —
Research Site Bend Oregon — —
Research Site Lake Oswego Oregon — —
Research Site Bensalem Pennsylvania — —
Research Site Feasterville Pennsylvania — —
Research Site Pittsburgh Pennsylvania — —
Research Site East Providence Rhode Island — —
Research Site Charleston South Carolina — —
Research Site Gaffney South Carolina — —
Research Site Greer South Carolina — —
Research Site Rapid City South Dakota — —
Research Site Watertown South Dakota — —
Research Site Boerne Texas — —
Research Site Dallas Texas — —
Research Site El Paso Texas — —
Research Site San Antonio Texas — —
Research Site Waco Texas — —
Research Site Provo Utah — —
Research Site Spokane Washington — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00449501, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 24, 2011 · Synced Oct 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00449501 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →